227 related articles for article (PubMed ID: 22950544)
21. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
[TBL] [Abstract][Full Text] [Related]
22. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
23. Beta
Hussein MH; Sobhy KE; Sabry IM; El Serafi AT; Toraih EA
Adv Med Sci; 2017 Mar; 62(1):193-201. PubMed ID: 28327457
[TBL] [Abstract][Full Text] [Related]
24. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report.
König P; Gayer D; Barbero GJ; Shaffer J
Pediatr Pulmonol; 1995 Oct; 20(4):205-14. PubMed ID: 8606849
[TBL] [Abstract][Full Text] [Related]
25. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
26. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis.
Nagy B; Nagy B; Fila L; Clarke LA; Gönczy F; Bede O; Nagy D; Újhelyi R; Szabó Á; Anghelyi A; Major M; Bene Z; Fejes Z; Antal-Szalmás P; Bhattoa HP; Balla G; Kappelmayer J; Amaral MD; Macek M; Balogh I
Chest; 2016 Sep; 150(3):661-72. PubMed ID: 27105680
[TBL] [Abstract][Full Text] [Related]
27. Serum zinc concentration in cystic fibrosis patients with CFTR I1234V mutation associated with pancreatic sufficiency.
AbdulWahab A; Abushahin A; Allangawi M; Chandra P; Abdel Rahman MO; Soliman A
Clin Respir J; 2017 May; 11(3):305-310. PubMed ID: 26096753
[TBL] [Abstract][Full Text] [Related]
28. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response.
Park HW; Yang MS; Park CS; Kim TB; Moon HB; Min KU; Kim YY; Cho SH
Allergy; 2009 May; 64(5):778-83. PubMed ID: 19183167
[TBL] [Abstract][Full Text] [Related]
29. ADRB2 Polymorphism and Salbutamol Responsiveness in Northern Indian Children with Mild to Moderate Exacerbation of Asthma.
Sahi PK; Shastri S; Lodha R; Gupta N; Pandey RM; Kabra SK; Kabra M
Indian Pediatr; 2016 Mar; 53(3):211-5. PubMed ID: 27029682
[TBL] [Abstract][Full Text] [Related]
30. Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.
Nielsen AO; Jensen CS; Arredouani MS; Dahl R; Dahl M
COPD; 2017 Aug; 14(4):451-460. PubMed ID: 28506092
[TBL] [Abstract][Full Text] [Related]
31. Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population.
Zhao H; Wu X; Dong CL; Wang BY; Zhao J; Cao XE
Genet Test Mol Biomarkers; 2017 Aug; 21(8):491-496. PubMed ID: 28753063
[TBL] [Abstract][Full Text] [Related]
32. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
[No Abstract] [Full Text] [Related]
33. IL1B polymorphisms modulate cystic fibrosis lung disease.
Levy H; Murphy A; Zou F; Gerard C; Klanderman B; Schuemann B; Lazarus R; García KC; Celedón JC; Drumm M; Dahmer M; Quasney M; Schneck K; Reske M; Knowles MR; Pier GB; Lange C; Weiss ST
Pediatr Pulmonol; 2009 Jun; 44(6):580-93. PubMed ID: 19431193
[TBL] [Abstract][Full Text] [Related]
34. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial.
Davies J; Sheridan H; Bell N; Cunningham S; Davis SD; Elborn JS; Milla CE; Starner TD; Weiner DJ; Lee PS; Ratjen F
Lancet Respir Med; 2013 Oct; 1(8):630-638. PubMed ID: 24461666
[TBL] [Abstract][Full Text] [Related]
35. Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.
Chaima S; Sondess HF; Khedija B; Ahmed M; Taieb M
Ann Biol Clin (Paris); 2020 Jun; 78(3):314-318. PubMed ID: 32540817
[TBL] [Abstract][Full Text] [Related]
36. Beta 2 Adrenergic Receptor Genetic Polymorphisms in Bronchial Asthma: Relationship to Disease Risk, Severity, and Treatment Response.
Mohamed-Hussein AAR; Sayed SS; Eldien HMS; Assar AM; Yehia FE
Lung; 2018 Dec; 196(6):673-680. PubMed ID: 30178312
[TBL] [Abstract][Full Text] [Related]
37. Beta-2-adrenergic receptor polymorphisms in cystic fibrosis.
Steagall WK; Barrow BJ; Glasgow CG; Mendoza JW; Ehrmantraut M; Lin JP; Insel PA; Moss J
Pharmacogenet Genomics; 2007 Jun; 17(6):425-30. PubMed ID: 17502834
[TBL] [Abstract][Full Text] [Related]
38. Clinical expression of cystic fibrosis in a large cohort of Italian siblings.
Terlizzi V; Lucarelli M; Salvatore D; Angioni A; Bisogno A; Braggion C; Buzzetti R; Carnovale V; Casciaro R; Castaldo G; Cirilli N; Collura M; Colombo C; Di Lullo AM; Elce A; Lucidi V; Madarena E; Padoan R; Quattrucci S; Raia V; Seia M; Termini L; Zarrilli F
BMC Pulm Med; 2018 Dec; 18(1):196. PubMed ID: 30577776
[TBL] [Abstract][Full Text] [Related]
39. Association of Gln27Glu and Arg16Gly polymorphisms in Beta2-adrenergic receptor gene with obesity susceptibility: a meta-analysis.
Zhang H; Wu J; Yu L
PLoS One; 2014; 9(6):e100489. PubMed ID: 24960039
[TBL] [Abstract][Full Text] [Related]
40. The Arg16Gly polymorphism of human beta2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people.
Chang TJ; Tsai MH; Jiang YD; Lee B; Lee KC; Lin JY; Chiu KC; Tai TY; Chuang LM
Clin Endocrinol (Oxf); 2002 Nov; 57(5):685-90. PubMed ID: 12390345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
